Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. PT Ikapharmindo Putramas Tbk was founded in 1978 and is headquartered in Jakarta Timur, Indonesia. PT Ikapharmindo Putramas Tbk is a subsidiary of PT Ikapharma Inti Mas.. |
Info | Profile |
---|---|
Name | Ikapharmindo Putramas Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 12/31/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Ikapharma Inti Mas | 78.12 | 78.12 |
Public < 5% | 20.0 | 20.0 |
Dra. Maudy Ratna Winata | 0.88 | 0.88 |
Drs. Titianus Winata | 0.62 | 0.62 |
Augustina Winata | 0.19 | 0.19 |
Eliza Arlena Winata | 0.19 | 0.19 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 78.12 | 78.12 |
Retail | 20.0 | 20.0 |
Individual | 1.88 | 1.88 |
Management | 0.0 | 0.0 |
Revenue Source | 2023 | 2022 |
---|
Revenue Region | 2023 | 2022 |
---|
Year | DPS | Yield [%] |
---|---|---|
2024 | 2.2 | 1.0 |
Stock | IKPM | IKPM |
Timeframe | Performance |
---|---|
1W % | 5.6 |
1Mo % | -7.4 |
3Mo % | -8.9 |
1Yr % | -26.6 |
Pivot | Points |
---|---|
R2 | 264 |
R1 | 244 |
S1 | 200 |
S2 | 176 |
Link download Laporan Keuangan emiten
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
IKPM | 76.61 | 371 B | 592 B | 412 B | 26 B | 5 B |
KLBF | 17.37 | 55.31 T | 55.45 T | 32,600 B | 5,070 B | 3,240 B |
SIDO | 14.09 | 16.65 T | 16.25 T | 3,920 B | 1,580 B | 1,170 B |
TSPC | 8.02 | 10.82 T | 9.70 T | 13,700 B | 2,110 B | 1,450 B |
SOHO | 19.76 | 7.93 T | 10.21 T | 10,100 B | 618 B | 463 B |
KAEF | -4.16 | 2.20 T | 12.80 T | 10,500 B | -9 B | -562 B |